论文部分内容阅读
癌肿患者不仅淋巴细胞总量有改变,而且其T细胞与B细胞所占比例数也有改变,有人认为此项变化可作诊断和预后观察标准。文献中有报道头颈癌患者在免疫化疗期间用玫瑰花结试验证实外周血中T细胞数没有减少。有人证明大多数癌症患者经治疗后T细胞数复近正常。还有人发现多数恶性黑瘤患者术后2周T细胞数目增多。但迄今尚无喉癌患者细胞免疫功能变化的动态观察。为此,作者们采用玫瑰花结试验和成淋巴细胞转化试验对18例40～60岁的喉癌患者,于喉切除前、后进行了检查,另以30名同年龄鼻中隔偏曲患者做为健康对照组,术后检查时间系术后12～15天。玫瑰花结试验检查结果:健康人血内有活性的T细胞平均占26.68±2.8％(364.8±18个/
Not only the total number of cancer patients with lymphocyte changes, but also the proportion of T cells and B cells also have a change in the number of people think this change can be used for diagnosis and prognosis of the standard. It has been reported in the literature that in patients with head and neck cancer during immunochemotherapy with rosette test confirmed that the number of T cells in peripheral blood did not decrease. It has been shown that most cancer patients have a nearly normal T cell count after treatment. Others found that the majority of malignant melanoma patients after 2 weeks increased the number of T cells. But so far no dynamic changes in cellular immune function in patients with laryngeal cancer. To this end, the authors used rosette test and lymphoblast transformation test 18 cases of 40 to 60-year-old laryngeal cancer patients before and after laryngectomy were examined, the other with the same age patients with nasal septal deviation as Healthy control group, postoperative examination time is 12 to 15 days after surgery. Rose knot test test results: Healthy people in the blood of T cells in an average of 26.68 ± 2.8% (364.8 ± 18 /